{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:35:35Z","timestamp":1790487335384,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009578","name":"Mizutani Foundation for Glycoscience","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009578","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.semcancer.2019.07.004","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T11:29:38Z","timestamp":1562239778000},"page":"108-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Tumorigenic functions of serglycin: Regulatory roles in epithelial to mesenchymal transition and oncogenic signaling"],"prefix":"10.1016","volume":"62","author":[{"given":"Dimitra","family":"Manou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos K.","family":"Karamanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achilleas D.","family":"Theocharis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.semcancer.2019.07.004_bib0005","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1021\/acs.chemrev.8b00354","article-title":"Proteoglycan chemical diversity drives multifunctional cell regulation and therapeutics","volume":"118","author":"Karamanos","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","article-title":"Extracellular matrix structure","volume":"97","author":"Theocharis","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.004_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/febs.13940","article-title":"Syndecans - key regulators of cell signaling and biological functions","volume":"284","author":"Afratis","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0020","article-title":"Proteoglycans remodeling in cancer: underlying molecular mechanisms","author":"Theocharis","year":"2017","journal-title":"Matrix bio.: J. Int. Soc. Matrix Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.004_bib0025","first-page":"276","article-title":"Insights into the key roles of proteoglycans in breast cancer biology and translational medicine","volume":"1855","author":"Theocharis","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.semcancer.2019.07.004_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2018.08.007","article-title":"Matrix modeling and remodeling: a biological interplay regulating tissue homeostasis and diseases","volume":"75-76","author":"Karamanos","year":"2019","journal-title":"Matrix bio.: J. Int. Soc. Matrix Biol."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9133-4_1","article-title":"The complex interplay between extracellular matrix and cells in tissues","volume":"1952","author":"Manou","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0040","doi-asserted-by":"crossref","DOI":"10.1111\/febs.14818","article-title":"The extracellular matrix as a multitasking player in disease","author":"Theocharis","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0045","first-page":"1","article-title":"Extracellular matrix: the driving force of mammalian diseases","volume":"71\u201372","author":"Iozzo","year":"2018","journal-title":"Matrix bio.: J. Int. Soc. Matrix Biol."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fonc.2013.00327","article-title":"Serglycin: at the crossroad of inflammation and malignancy","volume":"3","author":"Korpetinou","year":"2014","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.004_bib0055","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.4049\/jimmunol.1100806","article-title":"Serglycin: a structural and functional chameleon with wide impact on immune cells","volume":"187","author":"Kolset","year":"2011","journal-title":"J. Immunol."},{"issue":"46","key":"10.1016\/j.semcancer.2019.07.004_bib0060","doi-asserted-by":"crossref","first-page":"35116","DOI":"10.1074\/jbc.M601061200","article-title":"Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro","volume":"281","author":"Theocharis","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.004_bib0065","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.yexcr.2014.11.002","article-title":"Role for chondroitin sulfate glycosaminoglycan in NEDD9-mediated breast cancer cell growth","volume":"330","author":"Iida","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0070","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/690721","article-title":"Increased expression of serglycin in specific carcinomas and aggressive Cancer cell lines","volume":"2015","author":"Korpetinou","year":"2015","journal-title":"Biomed Res. Int."},{"issue":"7","key":"10.1016\/j.semcancer.2019.07.004_bib0075","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1038\/oncsis.2017.53","article-title":"SRGN-TGFbeta2 regulatory loop confers invasion and metastasis in triple-negative breast cancer","volume":"6","author":"Zhang","year":"2017","journal-title":"Oncogenesis"},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.004_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078157","article-title":"Serglycin is implicated in the promotion of aggressive phenotype of breast cancer cells","volume":"8","author":"Korpetinou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.07.004_bib0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.matbio.2018.05.011","article-title":"Serglycin promotes breast cancer cell aggressiveness: induction of epithelial to mesenchymal transition, proteolytic activity and IL-8 signaling","volume":"74","author":"Bouris","year":"2018","journal-title":"Matrix bio.: J. Int. Soc. Matrix Biol."},{"issue":"6","key":"10.1016\/j.semcancer.2019.07.004_bib0090","first-page":"2429","article-title":"SRGN promotes Colorectal Cancer metastasis as a Critical Downstream Target of HIF-1alpha, Cellular physiology and biochemistry : international journal of experimental cellular physiology","volume":"48","author":"Xu","year":"2018","journal-title":"biochem. Pharmacol."},{"issue":"17","key":"10.1016\/j.semcancer.2019.07.004_bib0095","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1038\/onc.2016.404","article-title":"Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner","volume":"36","author":"Guo","year":"2017","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.004_bib0100","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s12032-013-0707-4","article-title":"Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients","volume":"30","author":"He","year":"2013","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.004_bib0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/hed.23841","article-title":"Serglycin expression: an independent marker of distant metastases in nasopharyngeal carcinoma","volume":"38","author":"Chia","year":"2016","journal-title":"Head Neck"},{"issue":"11","key":"10.1016\/j.semcancer.2019.07.004_bib0110","doi-asserted-by":"crossref","first-page":"e2456","DOI":"10.1038\/cddis.2016.287","article-title":"Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK\/beta-catenin axis","volume":"7","author":"Chu","year":"2016","journal-title":"Cell Death Dis."},{"issue":"8","key":"10.1016\/j.semcancer.2019.07.004_bib0115","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1158\/0008-5472.CAN-10-3557","article-title":"Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis","volume":"71","author":"Li","year":"2011","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.004_bib0120","doi-asserted-by":"crossref","first-page":"16463","DOI":"10.18632\/oncotarget.14864","article-title":"Identification of novel follicular dendritic cell sarcoma markers, FDCSP and SRGN, by whole transcriptome sequencing","volume":"8","author":"Lorenzi","year":"2017","journal-title":"Oncotarget"},{"issue":"15","key":"10.1016\/j.semcancer.2019.07.004_bib0125","doi-asserted-by":"crossref","first-page":"24815","DOI":"10.18632\/oncotarget.15820","article-title":"Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression","volume":"8","author":"Roy","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.semcancer.2019.07.004_bib0130","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1074\/jbc.M113.532143","article-title":"Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization","volume":"289","author":"Purushothaman","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.004_bib0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1078\/0171-9335-00287","article-title":"Serglycin proteoglycan is sorted into zymogen granules of rat pancreatic acinar cells","volume":"82","author":"Biederbick","year":"2003","journal-title":"Eur. J. Cell Biol."},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.004_bib0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/03008200903288902","article-title":"Molecular interactions of MMP-13 C-terminal domain with chondrocyte proteins","volume":"51","author":"Zhang","year":"2010","journal-title":"Connect. Tissue Res."},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.004_bib0145","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbrc.2018.03.178","article-title":"Serglycin is involved in inflammatory response in articular mouse chondrocytes","volume":"499","author":"D\u2019Ascola","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.004_bib0150","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/10520295.2017.1399464","article-title":"Expression of serglycin in human disc is increased in degenerated discs and up-regulated in vitro by exposure to IL-1ss or TNF-alpha","volume":"93","author":"Gruber","year":"2018","journal-title":"Biotech. Histochem.: Off. Pub. Biol. Stain Commission"},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.004_bib0155","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/jcb.21235","article-title":"Interleukin-1beta selectively decreases the synthesis of versican by arterial smooth muscle cells","volume":"101","author":"Lemire","year":"2007","journal-title":"J. Cell. Biochem."},{"issue":"2\u20133","key":"10.1016\/j.semcancer.2019.07.004_bib0160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0304-4165(99)00096-3","article-title":"Stimulation of serglycin and CD44 mRNA expression in endothelial cells exposed to TNF-alpha and IL-1alpha","volume":"1428","author":"Kulseth","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.004_bib0165","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1074\/jbc.M110.151944","article-title":"Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha\/CXCL1","volume":"286","author":"Meen","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.semcancer.2019.07.004_bib0170","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.bbagen.2014.02.002","article-title":"Serglycin secretion is part of the inflammatory response in activated primary human endothelial cells in vitro","volume":"1840","author":"Reine","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.semcancer.2019.07.004_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145584","article-title":"Serglycin in quiescent and proliferating primary endothelial cells","volume":"10","author":"Reine","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.004_bib0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035128","article-title":"Breast cancer cells induce stromal fibroblasts to secrete ADAMTS1 for cancer invasion through an epigenetic change","volume":"7","author":"Tyan","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.semcancer.2019.07.004_bib0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014830","article-title":"Ultraviolet irradiation induces the accumulation of chondroitin sulfate, but not other glycosaminoglycans, in human skin","volume":"6","author":"Werth","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.004_bib0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2013.01.078","article-title":"Serglycin is a novel adipocytokine highly expressed in epicardial adipose tissue","volume":"432","author":"Imoto-Tsubakimoto","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"37","key":"10.1016\/j.semcancer.2019.07.004_bib0195","doi-asserted-by":"crossref","first-page":"26792","DOI":"10.1074\/jbc.M512889200","article-title":"Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-alpha secretion in response to lipopolysaccharide","volume":"281","author":"Zernichow","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.004_bib0200","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood.V97.2.449","article-title":"Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells","volume":"97","author":"Schick","year":"2001","journal-title":"Blood"},{"issue":"39","key":"10.1016\/j.semcancer.2019.07.004_bib0205","doi-asserted-by":"crossref","first-page":"40897","DOI":"10.1074\/jbc.M405856200","article-title":"Serglycin is essential for maturation of mast cell secretory granule","volume":"279","author":"Abrink","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.004_bib0210","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaci.2007.11.031","article-title":"Serotonin and histamine storage in mast cell secretory granules is dependent on serglycin proteoglycan","volume":"121","author":"Ringvall","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1-2","key":"10.1016\/j.semcancer.2019.07.004_bib0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1515\/BC-2011-220","article-title":"Mast cells express tyrosine hydroxylase and store dopamine in a serglycin-dependent manner","volume":"393","author":"Ronnberg","year":"2012","journal-title":"Biol. Chem."},{"issue":"7","key":"10.1016\/j.semcancer.2019.07.004_bib0220","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1182\/blood-2007-07-104703","article-title":"Serglycin proteoglycan deletion induces defects in platelet aggregation and thrombus formation in mice","volume":"111","author":"Woulfe","year":"2008","journal-title":"Blood"},{"issue":"39","key":"10.1016\/j.semcancer.2019.07.004_bib0225","doi-asserted-by":"crossref","first-page":"33411","DOI":"10.1074\/jbc.M501708200","article-title":"Serglycin-deficient cytotoxic T lymphocytes display defective secretory granule maturation and granzyme B storage","volume":"280","author":"Grujic","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.004_bib0230","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1182\/blood-2006-02-001719","article-title":"Neutrophil elastase depends on serglycin proteoglycan for localization in granules","volume":"109","author":"Niemann","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.004_bib0235","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1074\/jbc.M116.760660","article-title":"Platelet factor 4 binds to vascular proteoglycans and controls both growth factor activities and platelet activation","volume":"292","author":"Lord","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"37","key":"10.1016\/j.semcancer.2019.07.004_bib0240","doi-asserted-by":"crossref","first-page":"12187","DOI":"10.1021\/bi991046b","article-title":"Mechanism by which heparin proteoglycan modulates mast cell chymase activity","volume":"38","author":"Pejler","year":"1999","journal-title":"Biochemistry"},{"issue":"46","key":"10.1016\/j.semcancer.2019.07.004_bib0245","doi-asserted-by":"crossref","first-page":"42774","DOI":"10.1074\/jbc.M105531200","article-title":"Structural requirements and mechanism for heparin-induced activation of a recombinant mouse mast cell tryptase, mouse mast cell protease-6: formation of active tryptase monomers in the presence of low molecular weight heparin","volume":"276","author":"Hallgren","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.semcancer.2019.07.004_bib0250","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI118523","article-title":"A novel heparin-dependent processing pathway for human tryptase. Autocatalysis followed by activation with dipeptidyl peptidase I","volume":"97","author":"Sakai","year":"1996","journal-title":"J. clin. Invest."},{"issue":"12","key":"10.1016\/j.semcancer.2019.07.004_bib0255","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1111\/febs.12291","article-title":"In vitro reconstitution of complexes between pro-matrix metalloproteinase-9 and the proteoglycans serglycin and versican","volume":"280","author":"Malla","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0260","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/sj.leu.2404975","article-title":"Serglycin proteoglycan in hematologic malignancies: a marker of acute myeloid leukemia","volume":"21","author":"Niemann","year":"2007","journal-title":"Leukemia"},{"issue":"43","key":"10.1016\/j.semcancer.2019.07.004_bib0265","doi-asserted-by":"crossref","first-page":"73723","DOI":"10.18632\/oncotarget.20564","article-title":"Chondroitin sulfate proteoglycan serglycin influences protein cargo loading and functions of tumor-derived exosomes","volume":"8","author":"Purushothaman","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.004_bib0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103070","article-title":"Proteoglycans are attractive biomarkers and therapeutic targets in hepatocellular carcinoma","volume":"19","author":"Tanaka","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.semcancer.2019.07.004_bib0275","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.3748\/wjg.v20.i11.3025","article-title":"Mass spectrometry-based serum peptide profiling in hepatocellular carcinoma with bone metastasis","volume":"20","author":"He","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.semcancer.2019.07.004_bib0280","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/febs.12179","article-title":"Cell-surface serglycin promotes adhesion of myeloma cells to collagen type I and affects the expression of matrix metalloproteinases","volume":"280","author":"Skliris","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0285","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.semcancer.2018.08.009","article-title":"Cancer cell plasticity: impact on tumor progression and therapy response","volume":"53","author":"da Silva-Diz","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0290","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.semcancer.2018.06.006","article-title":"Emerging functional markers for cancer stem cell-based therapies: understanding signaling networks for targeting metastasis","volume":"53","author":"Marquardt","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0295","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.matbio.2016.05.003","article-title":"Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules","volume":"56","author":"Piperigkou","year":"2016","journal-title":"Matrix Biol."},{"issue":"2","key":"10.1016\/j.semcancer.2019.07.004_bib0300","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/eji.201040429","article-title":"Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma","volume":"41","author":"Skliris","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.semcancer.2019.07.004_bib0305","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pt.2018.11.004","article-title":"Fighting Cancer Using an oncofetal glycosaminoglycan-binding protein from malaria parasites","volume":"35","author":"Agerbaek","year":"2019","journal-title":"Trends Parasitol."},{"issue":"12","key":"10.1016\/j.semcancer.2019.07.004_bib0310","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1158\/1541-7786.MCR-16-0103","article-title":"Oncofetal chondroitin sulfate glycosaminoglycans are key players in integrin signaling and tumor cell motility","volume":"14","author":"Clausen","year":"2016","journal-title":"Mol. Cancer Res.: MCR"},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.004_bib0315","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1038\/s41467-018-05793-2","article-title":"The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner","volume":"9","author":"Agerbaek","year":"2018","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.semcancer.2019.07.004_bib0320","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/ijc.30575","article-title":"Burkitt lymphoma expresses oncofetal chondroitin sulfate without being a reservoir for placental malaria sequestration","volume":"140","author":"Agerbaek","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"41","key":"10.1016\/j.semcancer.2019.07.004_bib0325","doi-asserted-by":"crossref","first-page":"43529","DOI":"10.18632\/oncotarget.5984","article-title":"Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines","volume":"6","author":"Tsidulko","year":"2015","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.semcancer.2019.07.004_bib0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126688","article-title":"Loss of serglycin promotes primary tumor growth and vessel functionality in the RIP1-Tag2 mouse model for spontaneous insulinoma formation","volume":"10","author":"Hamilton","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.semcancer.2019.07.004_bib0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156151","article-title":"Targeting serglycin prevents metastasis in murine mammary carcinoma","volume":"11","author":"Roy","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.07.004_bib0340","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.matbio.2018.02.018","article-title":"Extracellular matrix functions in lung cancer","volume":"73","author":"Gotte","year":"2018","journal-title":"Matrix Biol."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0345","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-1-4939-7595-2_27","article-title":"Strategies to target matrix metalloproteinases as therapeutic approach in Cancer","volume":"1731","author":"Piperigkou","year":"2018","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.semcancer.2019.07.004_bib0350","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","article-title":"Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting","volume":"278","author":"Gialeli","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0355","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.semcancer.2017.08.002","article-title":"Epithelial-mesenchymal transition and inflammation at the site of the primary tumor","volume":"47","author":"Dominguez","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0360","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcancer.2018.08.002","article-title":"Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies","volume":"53","author":"Zhao","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0365","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.semcancer.2017.02.006","article-title":"The role of exosomes in cancer metastasis","volume":"44","author":"Steinbichler","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0370","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.matbio.2017.10.003","article-title":"Extracellular vesicles are integral and functional components of the extracellular matrix","volume":"75-76","author":"Rilla","year":"2017","journal-title":"Matrix bio.: J. Int. Soc. Matrix Biol."},{"key":"10.1016\/j.semcancer.2019.07.004_bib0375","article-title":"Proteases and glycosidases on the surface of exosomes: newly discovered mechanisms for extracellular remodeling","author":"Sanderson","year":"2017","journal-title":"Matrix bio.: J. Int. Soc. Matrix Biol."}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19300409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19300409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:38:31Z","timestamp":1760917111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X19300409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":75,"alternative-id":["S1044579X19300409"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.004","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumorigenic functions of serglycin: Regulatory roles in epithelial to mesenchymal transition and oncogenic signaling","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}